- 1. (1aR,2Z,4E,14R,15aR)-8-Chloro-1a,14,15,15a-Tetrahydro-9,11-dihydroxy-14-methyl-6H-oxireno[e][2]benzoxacyclotetradecin-6,12(7H)-dione
- [A macrocyclic antifungal antibiotic that inhibits signal-dependent transcriptional activation and induces differentiation in leukemia. (NCI) ( NCI )] (UMLS (NCI) C0207800) =Organic Chemical; Pharmacologic Substance ;
| - 51. ARA-C/ASP/DM/VP-16
- (UMLS (NCI) C0281322) =Therapeutic or Preventive Procedure
|
- 2. *Arbitrary
- (UMLS (HL7) C1264693) =Quantitative Concept =Kind of quantity;
| - 52. ARA-C/ASP/DNR
- (UMLS (NCI) C0279421) =Therapeutic or Preventive Procedure
|
- 3. 5a-Reductase Inhibition
- (UMLS (NCI) C0280703) =Therapeutic or Preventive Procedure
| - 53. ARA-C/ASP/DNR/MTX/PRED/VCR/VM-26
- (UMLS (NCI) C0278973) =Therapeutic or Preventive Procedure
|
- 4. A race-based population
- (UMLS (HL7) C1548149) =Idea or Concept =Nature of Abnormal Testing;
| - 54. ARA-C/ASP/DNR/PRED/VCR/VM-26
- (UMLS (NCI) C0280620) =Therapeutic or Preventive Procedure
|
- 5. A request for a tentative (e.g., "penciled in") appointment
- (UMLS (HL7) C1548407) =Idea or Concept =Appointment Type Codes;
| - 55. ARA-C/ASP/DOX/PRED/VCR
- (UMLS (NCI) C0279370) =Therapeutic or Preventive Procedure
|
- 6. A request to add a completed appointment, used to maintain records of completed appointments that did not appear in the schedule (e.g., STAT, walk-in, etc.)
- (UMLS (HL7) C1548405) =Intellectual Product =Appointment Type Codes;
| - 56. ARA-C/ASP/DOX/VM-26
- (UMLS (NCI) C0279052) =Therapeutic or Preventive Procedure
|
- 7. A routine check-up, such as an annual physical
- (UMLS (HL7) C1548400) =Intellectual Product =Appointment reason codes;
| - 57. ARA-C/ASP/G-CSF
- (UMLS (NCI) C0281547) =Therapeutic or Preventive Procedure
|
- 8. A-RAF Protein Kinase
- [Encoded by human ARAF1 Gene (MIL/RAF Family), cytoplasmic A-RAF [serine/threonine] Protein Kinase contains a DAG binding and a RBD domain, and is involved in transduction of mitogenic signals from cell membrane to nucleus. ( NCI )] (UMLS (NCI) C0100762) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 58. ARA-C/ASP/GM-CSF
- (UMLS (NCI) C0279448) =Therapeutic or Preventive Procedure
|
- 9. A28807, Rat Strain
- [Very docile. Susceptible to the induction of autoimmune thyroiditis. Low and intermediate antibody responses to 1 and 10 g BSA, respectively. Low antibody response to streptococcal group A carbohydrate; not linked to the MHC. High relative heart weight in 10-week old males (20/23). ( NCI )] (UMLS (NCI) C1510676) =Mammal ;
| - 59. ARA-C/ASP/IDA
- (UMLS (NCI) C0279418) =Therapeutic or Preventive Procedure
|
- 10. A990, Rat Strain
- [Resistant to Cysticercus. Susceptible to estrogen-induced mammary and adrenal tumors. Good reproduction. High open-field defecation (2/12, males, 3/12 females) and low ambulation (11/12), Harrington (1972). Low wheel activity (12/12) (Harrington 1971b). Aggressive towards handlers (Harrington 1981). ( NCI )] (UMLS (NCI) C1510678) =Mammal ;
| - 60. ARA-C/ASP/MePRDL/MTX/VCR/VP-16
- (UMLS (NCI) C0280909) =Therapeutic or Preventive Procedure
|
- 11. AR
- [A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (NCI) ( NCI )] (UMLS (NCI) C0003761) =Geographic Area ◊ [A state in the southern midwest United States. Its capital is Little Rock. ( NCI )] (UMLS (NCI) C0003790) Geographic Area ;
| - 61. ARA-C/ASP/MP/MTX
- (UMLS (NCI) C0796535) Asparaginase/Cytarabine/Mercaptopurine/Methotrexate =Therapeutic or Preventive Procedure ;
|
- 12. Ar element
- [noble gas element with the atomic symbol Ar, atomic number 18, and atomic weight 39.948; used in fluorescent tubes and in other situations where an inert atmosphere is desired. ( CSP )] (UMLS (CSP) C0003781) =Element, Ion, or Isotope ;
| - 62. ARA-C/ASP/MP/MTX/PRDL/VCR/VM-26
- (UMLS (NCI) C0280643) =Therapeutic or Preventive Procedure
|
- 13. AR-623
- (UMLS (NCI) C1328678) =Organic Chemical; Pharmacologic Substance
| - 63. ARA-C/ASP/MP/MTX/PRED/VM-26
- (UMLS (NCI) C0280649) =Therapeutic or Preventive Procedure
|
- 14. ara C
- [ ] (UMLS (CSP) C0733521) Ara-C =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 64. ARA-C/ASP/MP/MTX/VCR
- (UMLS (NCI) C0281119) =Therapeutic or Preventive Procedure
|
- 15. ARA-AC/G-CSF
- (UMLS (NCI) C0281467) =Therapeutic or Preventive Procedure ;
| - 65. ARA-C/ASP/MTX
- (UMLS (NCI) C0338275) =Therapeutic or Preventive Procedure ;
|
- 16. ARA-C/2-CdA
- (UMLS (NCI) C0393039) =Therapeutic or Preventive Procedure
| - 66. ARA-C/ASP/MTX/PRED/TG
- (UMLS (NCI) C0280893) =Therapeutic or Preventive Procedure
|
- 17. ARA-C/ASP
- (UMLS (NCI) C0278793) =Therapeutic or Preventive Procedure
| - 67. ARA-C/ASP/MTX/PRED/TG/VCR
- (UMLS (NCI) C0279060) =Therapeutic or Preventive Procedure
|
- 18. ARA-C/ASP/BCNU/TG
- (UMLS (NCI) C0279058) =Therapeutic or Preventive Procedure
| - 68. ARA-C/ASP/MTX/PRED/TG/VCR/VP-16
- (UMLS (NCI) C0281627) =Therapeutic or Preventive Procedure
|
- 19. ARA-C/ASP/CDDP/DM/VP-16
- (UMLS (NCI) C0281248) =Therapeutic or Preventive Procedure ;
| - 69. ARA-C/ASP/MTX/PRED/VCR
- (UMLS (NCI) C0280894) =Therapeutic or Preventive Procedure
|
- 20. ARA-C/ASP/CF/DM/MP/MTX/VCR
- (UMLS (NCI) C0796540) Asparaginase/Cytarabine/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine =Therapeutic or Preventive Procedure ;
| - 70. ARA-C/ASP/MTX/VCR
- (UMLS (NCI) C0280223) =Therapeutic or Preventive Procedure
|
- 21. ARA-C/ASP/CTX
- (UMLS (NCI) C0280514) =Therapeutic or Preventive Procedure ;
| - 71. ARA-C/ASP/VP-16
- (UMLS (NCI) C0280910) =Therapeutic or Preventive Procedure
|
- 22. ARA-C/ASP/CTX/DAVA/DM/DNR/MP/MTX/TG/VCR
- (UMLS (NCI) C0796542) Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine/Vindesine =Therapeutic or Preventive Procedure ;
| - 72. ARA-C/ATRA
- (UMLS (NCI) C0281237) =Therapeutic or Preventive Procedure ;
|
- 23. ARA-C/ASP/CTX/DM/DNR/MP/MTX/TG/VCR
- (UMLS (NCI) C0796450) Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine;
=Therapeutic or Preventive Procedure | - 73. ARA-C/ATRA/G-CSF
- (UMLS (NCI) C0281250) =Therapeutic or Preventive Procedure ;
|
- 24. ARA-C/ASP/CTX/DM/DOX/MP/VCR
- (UMLS (NCI) C0281364) =Therapeutic or Preventive Procedure
| - 74. ARA-C/AZA/CTX/TG/VCR
- (UMLS (NCI) C0279315) =Therapeutic or Preventive Procedure
|
- 25. ARA-C/ASP/CTX/DM/DOX/MTX/TG/VCR
- (UMLS (NCI) C0278795) =Therapeutic or Preventive Procedure
| - 75. ARA-C/AZA/DNR/PRED/VCR
- (UMLS (NCI) C0279355) =Therapeutic or Preventive Procedure
|
- 26. ARA-C/ASP/CTX/DM/DOX/TG/VCR
- (UMLS (NCI) C0280922) =Therapeutic or Preventive Procedure
| - 76. ARA-C/BCNU/CDDP/CTX/HU/MePRDL/PCB/VCR
- (UMLS (NCI) C0279487) =Therapeutic or Preventive Procedure
|
- 27. ARA-C/ASP/CTX/DM/DOX/VCR
- (UMLS (NCI) C0280641) =Therapeutic or Preventive Procedure
| - 77. ARA-C/BCNU/CTX/DNR/HU/MTX/TG/VCR
- (UMLS (NCI) C0279059) =Therapeutic or Preventive Procedure
|
- 28. ARA-C/ASP/CTX/DM/EPI/TG/VCR/VP-16
- (UMLS (NCI) C0338319) =Therapeutic or Preventive Procedure ;
| - 78. ARA-C/BCNU/CTX/VP-16
- (UMLS (NCI) C0105125) =Therapeutic or Preventive Procedure
|
- 29. ARA-C/ASP/CTX/DM/MP/MTX/VCR
- (UMLS (NCI) C0281365) =Therapeutic or Preventive Procedure
| - 79. ARA-C/BCNU/L-PAM/VP-16
- (UMLS (NCI) C0338248) =Therapeutic or Preventive Procedure
|
- 30. ARA-C/ASP/CTX/DNR/DOX/MP/VCR
- (UMLS (NCI) C0281319) =Therapeutic or Preventive Procedure
| - 80. ARA-C/BCNU/MTX/VCR
- (UMLS (NCI) C0338228) =Therapeutic or Preventive Procedure
|
- 31. ARA-C/ASP/CTX/DNR/MP/MTX/VCR
- (UMLS (NCI) C0281320) =Therapeutic or Preventive Procedure
| - 81. ARA-C/BLEO/CTX/DOX/G-CSF/MTX/PRED/VCR/VP-16
- (UMLS (NCI) C0338183) =Therapeutic or Preventive Procedure
|
- 32. ARA-C/ASP/CTX/DNR/MTX/PRED/TG/VCR
- (UMLS (NCI) C0280897) =Therapeutic or Preventive Procedure
| - 82. ARA-C/BLEO/CTX/DOX/GM-CSF/MTX/PRED/VCR/VP-16
- (UMLS (NCI) C0279406) =Therapeutic or Preventive Procedure
|
- 33. ARA-C/ASP/CTX/DOX/MTX/PRED/VCR
- (UMLS (NCI) C0056275) =Therapeutic or Preventive Procedure
| - 83. ARA-C/BLEO/CTX/DOX/MTX/PRED/VCR
- (UMLS (NCI) C0279774) =Therapeutic or Preventive Procedure
|
- 34. ARA-C/ASP/CTX/DOX/MTX/TG/VCR
- (UMLS (NCI) C0278919) =Therapeutic or Preventive Procedure
| - 84. ARA-C/BLEO/CTX/DOX/MTX/PRED/VCR/VP-16
- (UMLS (NCI) C0072146) =Therapeutic or Preventive Procedure ;
|
- 35. ARA-C/ASP/CTX/G-CSF
- (UMLS (NCI) C0281128) =Therapeutic or Preventive Procedure
| - 85. ARA-C/BLEO/CTX/PRED/VCR
- (UMLS (NCI) C0280057) =Therapeutic or Preventive Procedure
|
- 36. ARA-C/ASP/CTX/G-CSF/MP/VCR
- (UMLS (NCI) C0281012) =Therapeutic or Preventive Procedure
| - 86. ARA-C/BLEO/DOX/PRED/VCR
- (UMLS (NCI) C0062900) =Therapeutic or Preventive Procedure
|
- 37. ARA-C/ASP/CTX/IDA/MTX/PRED/VCR
- (UMLS (NCI) C0280728) =Therapeutic or Preventive Procedure ;
| - 87. ARA-C/BLEO/MTX/VCR
- (UMLS (NCI) C0279338) =Therapeutic or Preventive Procedure
|
- 38. ARA-C/ASP/CTX/MP
- (UMLS (NCI) C0796536) Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine =Therapeutic or Preventive Procedure ;
| - 88. ARA-C/BLEO/PRED/VCR
- (UMLS (NCI) C0279216) =Therapeutic or Preventive Procedure
|
- 39. ARA-C/ASP/CTX/MP/MTX
- (UMLS (NCI) C0280642) =Therapeutic or Preventive Procedure
| - 89. ARA-C/BRYO
- (UMLS (NCI) C0677767) =Therapeutic or Preventive Procedure
|
- 40. ARA-C/ASP/CTX/MP/MTX/VCR
- (UMLS (NCI) C0279859) =Therapeutic or Preventive Procedure
| - 90. ARA-C/BU/CTX
- (UMLS (NCI) C0281234) =Therapeutic or Preventive Procedure ;
|
- 41. ARA-C/ASP/CTX/MP/MTX/VP-16
- (UMLS (NCI) C0338264) =Therapeutic or Preventive Procedure
| - 91. ARA-C/BU/CTX/GM-CSF
- (UMLS (NCI) C0281376) =Therapeutic or Preventive Procedure ;
|
- 42. ARA-C/ASP/CTX/MP/VCR
- (UMLS (NCI) C0279247) =Therapeutic or Preventive Procedure ;
| - 92. ARA-C/BU/L-PAM
- (UMLS (NCI) C0281754) =Therapeutic or Preventive Procedure
|
- 43. ARA-C/ASP/CTX/MTX
- (UMLS (NCI) C0280820) =Therapeutic or Preventive Procedure ;
| - 93. ARA-C/BU/VP-16
- (UMLS (NCI) C0280749) =Therapeutic or Preventive Procedure
|
- 44. ARA-C/ASP/CTX/MTX/PRED/TG/VCR
- (UMLS (NCI) C0278895) =Therapeutic or Preventive Procedure
| - 94. ARA-C/CAF/CDDP
- (UMLS (NCI) C0280453) =Therapeutic or Preventive Procedure
|
- 45. ARA-C/ASP/CTX/MTX/VCR
- (UMLS (NCI) C0280278) =Therapeutic or Preventive Procedure
| - 95. ARA-C/CBDCA/DM
- (UMLS (NCI) C0280942) =Therapeutic or Preventive Procedure
|
- 46. ARA-C/ASP/CTX/PRED/VCR
- (UMLS (NCI) C0279202) =Therapeutic or Preventive Procedure
| - 96. ARA-C/CBDCA/DM/GM-CSF
- (UMLS (NCI) C0280943) =Therapeutic or Preventive Procedure
|
- 47. ARA-C/ASP/CTX/TG/VCR
- (UMLS (NCI) C0280710) =Therapeutic or Preventive Procedure
| - 97. ARA-C/CBDCA/HU
- (UMLS (NCI) C0281511) =Therapeutic or Preventive Procedure
|
- 48. ARA-C/ASP/DHAD/DM/VP-16
- (UMLS (NCI) C0796541) Asparaginase/Cytarabine/Dexamethasone/Etoposide/Mitoxantrone =Therapeutic or Preventive Procedure ;
| - 98. ARA-C/CBDCA/IDA
- (UMLS (NCI) C0281201) =Therapeutic or Preventive Procedure
|
- 49. ARA-C/ASP/DM/DOX/MP/VCR
- (UMLS (NCI) C0281363) =Therapeutic or Preventive Procedure
| - 99. ARA-C/CBDCA/MePRDL/VP-16
- (UMLS (NCI) C0280807) =Therapeutic or Preventive Procedure ;
|
- 50. ARA-C/ASP/DM/DOX/TG/VCR
- (UMLS (NCI) C0279140) =Therapeutic or Preventive Procedure
| - 100. ARA-C/CBDCA/VP-16
- (UMLS (NCI) C0280825) =Therapeutic or Preventive Procedure
|